Private Advisor Group, LLC Rigel Pharmaceuticals Inc Transaction History

Private Advisor Group, LLC

  • $15.6 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022
SELL
$2.36 - $3.57 $23,600 - $35,700
-10,000 Closed
0 $0
Q2 2021

Aug 12, 2021
SELL
$3.09 - $4.54 $7,725 - $11,350
-2,500 Reduced 20.0%
10,000 $43,000
Q1 2021

Apr 22, 2021
BUY
$3.35 - $4.93 $41,875 - $61,625
12,500 New
12,500 $43,000

Others Institutions Holding RIGL

# of Institutions
9
Shares Held
334K
Call Options Held
0
Put Options Held
0
View Full List

About RIGEL PHARMACEUTICALS INC

RIGL Quotes by TradingView
  • Ticker RIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 172,836,000
  • Market Cap $2.81B
  • Description
  • Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...
More about RIGL
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email